On Mar 19, 2026, NRXS reported earnings of -0.17 USD per share (EPS) for Q4 25, beating the estimate of -0.21 USD, resulting in a 22.48% surprise. Revenue reached 968.13 thousand, compared to an expected 867.00 thousand, with a 11.66% difference. The market reacted with a +2.43% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 3 analysts forecast an EPS of -0.19 USD, with revenue projected to reach 1.43 million USD, implying an increase of 11.76% EPS, and increase of 47.50% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
KORU Medical Systems, Inc. Common Stock (DE)
Report Date
Mar 12, 2026 For Q4 25
Estimate
-
Actual
-$0.01
Surprise
-
CareCloud, Inc. Common Stock
Report Date
Mar 12, 2026 For Q4 25
Estimate
$0.03
Actual
$0.03
Surprise
-15.97%
Nyxoah SA Ordinary Shares
Report Date
Mar 19, 2026 For Q4 25
Estimate
-$0.55
Actual
-$0.58
Surprise
-5.51%
Health Catalyst, Inc Common Stock
Report Date
Mar 12, 2026 For Q4 25
Estimate
$0.09
Actual
$0.08
Surprise
-13.79%
Heartflow, Inc. Common Stock
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$0.17
Actual
-$0.12
Surprise
+30.31%
Heartbeam, Inc. Common Stock
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.13
Actual
-$0.14
Surprise
-0.72%
HeartSciences Inc. Common Stock
Report Date
Mar 16, 2026 For Q3 26
Estimate
-$0.86
Actual
-$0.63
Surprise
+27.34%
FAQ
What were Neuraxis, Inc.'s earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Neuraxis, Inc. reported EPS of -$0.17, beating estimates by 22.48%, and revenue of $968.13K, 11.66% above expectations.
How did the market react to Neuraxis, Inc.'s Q4 2025 earnings?
The stock price moved up 2.43%, changed from $6.99 before the earnings release to $7.16 the day after.
When is Neuraxis, Inc. expected to report next?
The next earning report is scheduled for May 12, 2026.
What are the forecasts for Neuraxis, Inc.'s next earnings report?
Based on 3
analysts, Neuraxis, Inc. is expected to report EPS of -$0.19 and revenue of $1.43M for Q1 2026.